Yıl: 2022 Cilt: 10 Sayı: 1 Sayfa Aralığı: 88 - 95 Metin Dili: İngilizce DOI: 10.14235/bas.galenos.2021.5544 İndeks Tarihi: 15-05-2023

Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding

Öz:
Objective: The aim of this study is to evaluate the efficacy of the Algan Hemostatic Agent (AHA) available in three different physical form (liquid, powder and sponge absorbed) in the femoral artery incision model in rats. Methods: A total of sixty-four 5-7 weeks old rats were used in the study. Rats were randomly divided into 8 groups each consisting of eight rats (4 groups heparinized and 4 groups non-heparinized). An experimental femoral artery incision was created. As a control, physiological saline absorbed sponge was applied. AHA liquid, AHA powder and AHA sponge absorbed forms were applied to the experimental groups. Results: Upon application to the bleeding sites, all the AHA forms stopped bleeding in a significantly shorter time compared to the control group (p<0.05). In contrast, bleeding in control group could not be controlled within 4 minutes. The best result was in AHA powder form and it was able to control bleeding in the non-heparinized group at 87.5% in the first minute and 12.5% in the second minute. In the heparinize group, the AHA powder form was able to control the bleeding at 62.5% in the first minute and 37.5% in the second minute. Conclusion: This study shows that AHA is a highly effective and promising hemostatic agent in bleeding control.
Anahtar Kelime:

Ratlarda Femoral Arter Kanama Modelinde Bitki Bazlı Algan Hemostatik Ajanın Etkinliğinin Araştırılması

Öz:
Amaç: Bu çalışmanın amacı, sıçanlarda femoral arter insizyon modelinde üç farklı fiziksel formda (sıvı, toz ve spança emdirilmiş) bulunan Algan Hemostatik Ajanın (AHA) etkinliğini değerlendirmektir. Yöntemler: Çalışmada toplam 64 adet 5-7 haftalık rat kullanıldı. Ratlar rastgele olarak her biri sekiz rattan oluşan 4 gruba (4 grup heparinize ve 4 grup nonheparinize) ayrıldı. Deneysel femoral arter insizyonu oluşturuldu. Kontrol olarak serum fizyolojik emdirilmiş spanç uygulandı. Deney gruplarına AHA sıvısı, AHA tozu ve AHA sıvısı emdirilmiş spanç formları uygulandı. Bulgular: Kanama bölgelerine uygulanan tüm AHA formları kontrol grubuna göre anlamlı olarak daha kısa sürede kanamayı durdurdu (p<0.05). Buna karşılık, kontrol grubunda kanama 4 dakika içinde kontrol edilemedi. En iyi sonuç AHA toz formundaydı ve heparinize olmayan grupta kanamayı birinci dakikada %87,5 ve ikinci dakikada %12,5 oranında kontrol edebildi. Heparinize grupta AHA toz formu birinci dakikada %62,5, ikinci dakikada ise %37,5 oranında kanamayı kontrol edebildi. Sonuç: Bu çalışma, AHA'nın kanama kontrolünde oldukça etkili ve umut verici bir hemostatik ajan olduğunu göstermektedir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Abacıoğlu S, Aydın K, Büyükcam F, Abacıoğlu S, Aydın K, Büyükcam F, Kaya U, Işık B, Karakılıç ME. Comparison of the efficiencies of buffers containing Ankaferd and Chitosan on hemostasis in an experimental rat model with femoral artery bleeding. Turk J Hematol 2016;33:48-52.
  • 2. Aktop S, Emekli-Alturfan E, Ozer C, Gonul O, Garip H, et al. Effects of Ankaferd Blood Stopper and Celox on the tissue factor activities of warfarin-treated rats. Clin Appl Thromb Hemost 2014;20:16-21.
  • 3. Bennett BL, Littlejohn LF, Kheirabadi BS, Butler FK, Kotwal RS, Dubick MA, et al. Management of External Hemorrhage in Tactical Combat Casualty Care: Chitosan-Based Hemostatic Gauze Dressings. JSOM 2014;14:12-29.
  • 4. Bracey A, Shander A, Aronson S, Boucher BA, Calcaterra D, Chu MWA, et al. The use of topical hemostatic agents in cardiothoracic surgery. Ann Thorac Surg 2017;104:353-60.
  • 5. Brunett PH, Cameron PA. Trauma in adults. 1669-1676. In: Tintinalli JE, Stapczynski JS, Ma OJ, Cline DM, Cydulka RK, Meckler GD, Editors. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. McGraw Hill, New York. 2010.
  • 6. Ersoy G, Kaynak MF, Yilmaz O, Rodoplu U, Maltepe F, Gokmen N. Hemostatic effects of microporous polysaccharide hemosphere in a rat model with severe femoral artery bleeding. Adv Ther 2007;24:485-92.
  • 7. Glickman M, Gheissari A, Money S, Martin J, Ballard JL; CoSeal Multicenter Vascular Surgery Study Group. A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/ thrombin: results of a randomized controlled trial. Arch Surg 2002;137:326-31.
  • 8. Hanks JB, Kjaergard HK, Hollingsbee DA. A comparison of the hemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose (Surgicel) in multiple surgical procedures. Eur Surg Res 2003;35:439-44.
  • 9. Huri E, Akgül KT, Yücel MÖ, Astarcı HM, Üstün H, Germiuanoğlu RC. The second step in vitro trial of Ankaferd® Bloodstopper®: comparison with other hemostatic agents. Turk J Med Sci 2011;41:7-15.
  • 10. Jackson MR. New and potential uses of fibrin sealants as an adjunct to surgical hemostasis. Am J Surg 2001;182:36-9.
  • 11. Karahaliloğlu Z, Demirbilek M, Ulusoy İ, Gümüşkaya B, Denkbaş EB. Hemostatic activities of nano/microporous bilayer dressings in a femoral artery bleeding rat model. J Appl Polym Sci 2016;133:43657.
  • 12. Letourneau PA, McManus M, Sowards K, Wang W, Wang YW, Matijevic N, et al. Aged plasma transfusion increases mortality in a rat model of uncontrolled hemorrhage. J Trauma 2011;71:1115-9.
  • 13. Lew WK, Weaver FA. Clinical use of topical thrombin as a surgical hemostat. Biologics 2008;2:593-9.
  • 14. Lih E, Lee JS, Park KM, Park KD. Rapidly curable chitosan-PEG hydrogels as tissue adhesives for hemostasis and wound healing. Acta biomater 2012;8:3261-9.
  • 15. Midi A, Kumandaş A, Ekici H, Arda S, Karahan S, Şimşek AK, et al. Investigation of the effectiveness of algan hemostatic agent in renal venous bleeding model in rats. EJMI 2018;2:129-32.
  • 16. Midi A, Ozyurek HE, Karahan S, Ekici H, Kumandas A, Turkmen I, et al. Investigation of efficacy of the plant based algan hemostatic agent in hepatectomy bleeding model in rats. EJMI 2018;2:195-201.
  • 17. Midi A, Ekici H, Kumandas A, Durmus O, Bodıc B, Tıryakı M, et al. Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats. Marmara Med J 2019;32:27-32.
  • 18. Midi A, Kumandas A, Ekici H, Bayraktar F, Karapirli K, Karahan S, et al. Investigation of the Efficacy of Algan Hemostatic Agent in Liver Laceration Model in Rats. EJMO 2019;3:37-42.
  • 19. Ohta S, Nishiyama T, Sakoda M, Machioka K. Development of carboxymethyl cellulose nonwoven sheet as a novel hemostatic agent. J Biosci Bioeng 2015;119:718-23.
  • 20. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001;233:88-96.
  • 21. Schreiber MA, Neveleff DJ. Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings. AORN J 2011;94:1-20.
  • 22. Spotnitz WD, Burks S. Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 2008;48:1502-16.
  • 23. Spotnitz WD, Burks S. State-of-the-art review: hemostats, sealants, and adhesives II. Update as well as how and when to use the components of the surgical toolbox. Clin Appl Thomb Hemost 2010;16:497-514.
  • 24. Spotnitz WD. Hemostats, sealants, and adhesives: a practical guide for the surgeon. Am Surg 2012;78:1305-21.
  • 25. Srivastava CM, Purwar R. Chitosan finished Antheraea mylitta silk fibroin nonwoven composite films for wound dressing. J Appl Polym Sci 2017;134:44341.
  • 26. Su Z, Izumi T, Thames EH, Lawson JH, Ortel TL. Antiphospholipid antibodies after surgical exposure to topical bovine thrombin. J Lab Clin Med 2002;139:349-56.
  • 27. Ward KR, Tiba MH, Holbert WH, Blocher CR, Draucker GT, Proffitt EK, et al. Comparison of a new hemostatic agent to current combat hemostatic agents in a swine model of lethal extremity arterial hemorrhage. J Trauma 2007;63:276-83.
  • 28. Xu HX, Yan YU, Wang XY, Ma K, Chao Y, Sun PJ, et al. Hemostatic effect of a medical polysaccharide hemostatic healing sponge on hemostasis of bleeding from femoral artery in pigs. Med J Chin PLA 2015;40:245-7.
  • 29. Yan D, Hu S, Zhou Z, Zeenat S, Cheng F, Li Y, et al. Different chemical groups modification on the surface of chitosan nonwoven dressing and the hemostatic properties. Int J Biol Macromol 2018;107:463-9.
APA Ekici H, KUMANDAS A, Ozbaykus A, Dizdaroglu H, Midi A, balık m, Yesilada E (2022). Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. , 88 - 95. 10.14235/bas.galenos.2021.5544
Chicago Ekici Hüsamettin,KUMANDAS ALI,Ozbaykus Abdullah Canberk,Dizdaroglu Hazal,Midi Ahmet,balık mehmet sabri,Yesilada Erdem Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. (2022): 88 - 95. 10.14235/bas.galenos.2021.5544
MLA Ekici Hüsamettin,KUMANDAS ALI,Ozbaykus Abdullah Canberk,Dizdaroglu Hazal,Midi Ahmet,balık mehmet sabri,Yesilada Erdem Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. , 2022, ss.88 - 95. 10.14235/bas.galenos.2021.5544
AMA Ekici H,KUMANDAS A,Ozbaykus A,Dizdaroglu H,Midi A,balık m,Yesilada E Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. . 2022; 88 - 95. 10.14235/bas.galenos.2021.5544
Vancouver Ekici H,KUMANDAS A,Ozbaykus A,Dizdaroglu H,Midi A,balık m,Yesilada E Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. . 2022; 88 - 95. 10.14235/bas.galenos.2021.5544
IEEE Ekici H,KUMANDAS A,Ozbaykus A,Dizdaroglu H,Midi A,balık m,Yesilada E "Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding." , ss.88 - 95, 2022. 10.14235/bas.galenos.2021.5544
ISNAD Ekici, Hüsamettin vd. "Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding". (2022), 88-95. https://doi.org/10.14235/bas.galenos.2021.5544
APA Ekici H, KUMANDAS A, Ozbaykus A, Dizdaroglu H, Midi A, balık m, Yesilada E (2022). Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. Bezmiâlem Science, 10(1), 88 - 95. 10.14235/bas.galenos.2021.5544
Chicago Ekici Hüsamettin,KUMANDAS ALI,Ozbaykus Abdullah Canberk,Dizdaroglu Hazal,Midi Ahmet,balık mehmet sabri,Yesilada Erdem Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. Bezmiâlem Science 10, no.1 (2022): 88 - 95. 10.14235/bas.galenos.2021.5544
MLA Ekici Hüsamettin,KUMANDAS ALI,Ozbaykus Abdullah Canberk,Dizdaroglu Hazal,Midi Ahmet,balık mehmet sabri,Yesilada Erdem Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. Bezmiâlem Science, vol.10, no.1, 2022, ss.88 - 95. 10.14235/bas.galenos.2021.5544
AMA Ekici H,KUMANDAS A,Ozbaykus A,Dizdaroglu H,Midi A,balık m,Yesilada E Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. Bezmiâlem Science. 2022; 10(1): 88 - 95. 10.14235/bas.galenos.2021.5544
Vancouver Ekici H,KUMANDAS A,Ozbaykus A,Dizdaroglu H,Midi A,balık m,Yesilada E Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. Bezmiâlem Science. 2022; 10(1): 88 - 95. 10.14235/bas.galenos.2021.5544
IEEE Ekici H,KUMANDAS A,Ozbaykus A,Dizdaroglu H,Midi A,balık m,Yesilada E "Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding." Bezmiâlem Science, 10, ss.88 - 95, 2022. 10.14235/bas.galenos.2021.5544
ISNAD Ekici, Hüsamettin vd. "Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding". Bezmiâlem Science 10/1 (2022), 88-95. https://doi.org/10.14235/bas.galenos.2021.5544